iifl-logo

Senores Pharmaceuticals Ltd Historical Data

Add as a Preferred Source on Google
1,492.4
(1.13%)
Aug 12, 2026|09:01:14 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Senores Pharmaceuticals Ltd Historical Data

13/07/2026calendar-icon
13/08/2026calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

13-Jul-2026

1,411.7

1,440.81,376.11,435.523,97742,16,15,151.81,06,736

14-Jul-2026

1,420

1,460.41,4201,451.815,74231,80,36,551.194,471

15-Jul-2026

1,468.6

1,4851,453.51,480.913,07725,75,12,046.11,01,512

16-Jul-2026

1,483.1

1,509.81,444.41,452.916,09335,44,57,619.31,05,016

17-Jul-2026

1,455

1,461.91,392.81,405.118,58233,48,13,982.71,02,026

20-Jul-2026

1,395

1,414.31,380.41,38519,50123,58,79,955.883,606

21-Jul-2026

1,385

1,4101,368.71,40412,26418,12,29,846.354,378

22-Jul-2026

1,419

1,427.91,342.51,393.431,74250,35,64,816.41,02,650

23-Jul-2026

1,390

1,449.91,385.11,395.623,34337,79,92,640.31,09,591

24-Jul-2026

1,390

1,403.61,371.51,387.511,24917,01,45,084.646,713

27-Jul-2026

1,408.3

1,443.71,3781,41224,78459,55,26,364.31,57,869

28-Jul-2026

1,408.3

1,414.81,287.91,323.961,8631,54,13,90,120.54,42,081

29-Jul-2026

1,339

1,344.51,3101,318.314,77129,10,30,352.380,394

30-Jul-2026

1,318.3

1,321.51,279.71,292.414,10425,84,09,961.481,670

31-Jul-2026

1,298.9

1,329.91,293.61,305.712,14920,36,34,158.763,506

03-Aug-2026

1,326.6

1,364.41,312.11,355.315,82526,84,59,268.593,928

04-Aug-2026

1,369

1,3701,3441,360.57,49414,16,83,67047,029

05-Aug-2026

1,371.5

1,3741,306.11,323.322,41557,47,26,3952,07,281

06-Aug-2026

1,335

1,345.61,3241,328.57,29412,05,93,903.144,139

07-Aug-2026

1,328.5

1,359.91,3101,342.622,06529,01,29,765.583,768

10-Aug-2026

1,347.7

1,4381,325.11,422.233,27378,97,00,026.42,91,570

11-Aug-2026

1,429.3

1,496.31,410.81,475.722,82360,75,77,192.51,81,089

Senores Pharmaceuticals Ltd: Related NEWS

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

The acquisition will be carried out in two tranches and has received approval from the management committee of the company’s board.

16 Dec 2025|11:27 AM
Read More
Dr. Reddy’s Laboratories Sells 14 ANDAs to Senores Pharma

Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.

5 Mar 2025|11:05 AM
Read More
Senores Stock Dips from High, Remains Above IPO Price

Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.

30 Dec 2024|04:08 PM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.